Skip to content

TIMALVEOLE

Active Private limited companyfounded 2009active for 17 yearsAvenue François Cornesse 74, 4920 AywailleKBO/BCE: BE 0812.039.953 #8 oldest company in Aywaille, Health and social work sector

Lifetime

17 annual accounts with figures on one time axis
peak of €85,400 in 2009
€44,639▲ 59.6%
lowest -€36,892 in 2023
€29,439▲ 51.2%
peak of €286,407 in 2022
€152,970▼ 13.6%
€49,454▲ 22.0%
Board1 name since 2009
1 director
Documentsfilings and deeds
27-08-202627 days late
2025micro format
Gross margin from €27,971 to €44,639Result from €19,472 to €29,439Dividend €53,465Equity from €176,995 to €152,970Debts from €40,546 to €49,454Investments €18,820

Key points

from the 2025 annual accounts

Equity

€152,970 ▼ 13.6%
176,9952024+29,439Profit-53,465Dividend152,9702025

TIMALVEOLE paid out €53,465 in dividends. That is 182% of the 2025 profit.

Investments

€18,820 5.7 times depreciation
20212022202320242025

Green is investment, beige is depreciation.

Filings

17 annual accounts since 2009
AprilJune31 JulyOctober2010201520202025

Nine of the last ten came late. The 2021 accounts came in latest, 87 days after the end of the period.

Checked score

Bankruptcy probability within 12 months

Financial strength

Score breakdown

Comparable companies, two years later

In July 2024, 34,724 companies had the same profile as TIMALVEOLE has now. Each dot stands for 87 companies, two years later.

95.3%
were still trading
4.0%
stopped another way
0.7%
went bankrupt
  • Micro
  • 10 to 20 years old
  • solvency 30% or more
  • a profit of 5% of the balance sheet or more
Test of the method

The method was tested on the 497,894 companies of July 2024. Each company was given the bankruptcy share of the same profile a year earlier, in July 2023. The expectation was that 1.7% would go bankrupt within 24 months. In fact 1.8% went bankrupt.

The companies in ten equal groups, from the lowest to the highest expected share
Group Expected Actual
1 0.2% 0.2%
2 0.4% 0.5%
3 0.6% 0.6%
4 0.7% 0.8%
5 0.9% 1.0%
6 1.4% 1.6%
7 1.7% 1.8%
8 1.9% 2.0%
9 3.1% 3.3%
10 5.9% 6.4%

A company that went bankrupt had a higher expected share than one that kept going in 74.5% of comparisons. The level depends on the economy. In a year with more bankruptcies than the year before, the actual share is higher than the expected one.

This is an observation about 34,724 companies, not a prediction for TIMALVEOLE. The sector does not count, because the KBO no longer lists a sector for a company that has stopped. By sector, mostly the survivors would count, which would paint too rosy a picture.

Credit verdict

Credit check for an amount and term of your choice

Show the recommended maximum and see how the verdict changes with amount, term and advance.

The scores and ratios are Checked's own calculations, not a credit decision.

Signals

Board and ownership

Director
  • 60 sharesdeed of 11-06-2009
Board & ownership

Recent changes

Registered in the Peppol Directory Reachable for e-invoices through 0208:0812039953
reappointed as director Discharge granted to · General meeting of 18-10-2023 · Gazette deed
New establishment in Arlon Avenue Victor-Tesch 53
Registered office moved within Aywaille The registered office moved from Paradis 48, 4920 AYWAILLE to Avenue François Comesse 74 4920 AYWAILLE · Gazette deed
All 33 events

Comparable companies

same main activity, similar in size and age
Company
TIMALVEOLE Aywaille €202,423 €44,639 75.6% -
DOCTEUR COLINET STEPHANIE Chaudfontaine €182,415 €46,036 69.3% -
Docteur Sonja VILLE Geer €219,791 €44,735 63.6% -
DR. ELS DECROP Sint-Katelijne-Waver €194,171 €43,480 95.8% -
Dr. Sevenants Lieve, pediatrie Aarschot €195,491 €42,556 81.7% -
DOCTEUR MICHEL Genappe €217,061 €42,105 91.1% -
DOKTER BENOIT VAN INNIS - ORTHOPEDIST Wortegem-Petegem €230,179 €43,375 23.2% -

These companies have the same main activity as TIMALVEOLE: specialist medical practice (NACE 86220). They are comparable in size and age: total assets between €182,000 and €230,000, founded between 2007 and 2009.

Official details

Source: KBO
Status
Active since 03-06-2009Normal situation
Activity
Specialist medical practiceNACE 86220
Establishment units
2.179.632.2636700 Arlon, since 29-07-2009
2.305.275.6706700 Arlon, since 09-10-2017
Financial year end
31 December
Peppol
Reachable since 29-03-2026
Company details

Annual accounts 2025

≈ €140,000estimated
€202,423▼ 6.9%
Filing
Filed on 27-08-2026
Financials

Insights on TIMALVEOLE

TIMALVEOLE files the micro format. That format states no turnover. The gross margin fell from €85,400 in 2009 to €44,639 in 2025.

Sources: KBO register, filings at the National Bank, Belgian Official Gazette. Click a figure with a dotted line for the item and the filing.

Key facts about TIMALVEOLE

What is the company number of TIMALVEOLE?
The company number of TIMALVEOLE is 0812.039.953. The VAT number is the same number with BE in front: BE 0812.039.953.
Where is TIMALVEOLE based?
The registered office is at Avenue François Cornesse 74, 4920 Aywaille.Company details
What does TIMALVEOLE do?
According to the KBO register, the main activity is specialist medical practice (NACE 86220).
What is the legal form of TIMALVEOLE?
TIMALVEOLE is a private limited company (BV).
When was TIMALVEOLE founded?
TIMALVEOLE was founded on 03-06-2009.
Is TIMALVEOLE still active?
Yes, TIMALVEOLE is an active enterprise in the KBO register.
What is the turnover of TIMALVEOLE?
The turnover in financial year 2025 is about €140,000. This figure is estimated from the gross margin of €44,639 and 47 comparable companies (NACE 86). It probably lies between €99,000 and €190,000.Financials
Is TIMALVEOLE profitable?
In financial year 2025, TIMALVEOLE made a profit of €29,439.
Where can I find the annual accounts of TIMALVEOLE?
TIMALVEOLE filed 17 annual accounts with the National Bank of Belgium, the latest for financial year 2025.
When are the next annual accounts of TIMALVEOLE due?
TIMALVEOLE must file the annual accounts for financial year 2026 by 31-07-2027.Timeline

Next steps

See how customers, suppliers and banks see your own company and what to improve first.

Keep this company with today's facts in a case file.